What Are Core Scientific Inc.'s Key Financial Figures?

Fiscal yearFY2025
ended December 31, 2025
FY2024
ended December 31, 2024
FY2023
ended December 31, 2023
FY2022
ended December 31, 2022
Revenue$319 million$511 million$502 million$640 million
Operating income-$246 million-$142 million$9 million-$2.1 billion
Operating margin-77.0%-27.8%1.8%-329.5%
Net income-$289 million-$1.4 billion-$246 million-$2.1 billion
Net margin-90.5%-281.6%-49.1%-335.2%
Operating cash flow$278 million$43 million$65 million$205 million
Capital expenditures$729 million$95 million$16 million$384 million
Free cash flow-$451 million-$52 million$49 million-$179 million

Operating margin narrowed by 49.2 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was -$451 million against net income of -$289 million; cash generation fell short of reported earnings, which is worth reconciling in the cash flow statement.

Bar chart of Core Scientific Inc. revenue, operating income, net income for fiscal 2022 to 2025. In fiscal 2025, revenue was $319 million, operating income negative $246 million and net income negative $289 million.
Core Scientific Inc. revenue, operating income and net income by fiscal year, from the figures in the table above. Select the chart to open it full size.
Line chart of Core Scientific Inc. operating margin and net margin for fiscal 2022 to 2025. In fiscal 2025, operating margin was -77.0% and net margin was -90.5%.
Core Scientific Inc. operating margin and net margin by fiscal year: operating income and net income as a share of revenue. Select the chart to open it full size.
Bar chart of Core Scientific Inc. operating cash flow, capital expenditures, free cash flow for fiscal 2022 to 2025. In fiscal 2025, operating cash flow was $278 million, capital expenditures was $729 million, free cash flow was negative $451 million.
Core Scientific Inc. operating cash flow, capital expenditures and free cash flow by fiscal year. Select the chart to open it full size.

What Does Core Scientific Inc.'s Balance Sheet Show?

Cash and cash equivalents$311 million
Long-term debt$1.1 billion
Total assets$2.3 billion
Total liabilities$3.3 billion
Shareholders' equity-$963 million
Current ratio1.1x

Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.

Where These Numbers Come From

Every figure on this page is a value Core Scientific Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001628280-26-013305 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 12, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.

Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.

Frequently Asked Questions

What was Core Scientific Inc.'s revenue in fiscal 2025?

Core Scientific Inc. reported revenue of $319 million for the fiscal year ended December 31, 2025, according to its SEC filings.

What is Core Scientific Inc.'s operating margin?

Core Scientific Inc.'s operating margin was -77.0% in fiscal 2025: operating income of -$246 million on revenue of $319 million.

How much free cash flow did Core Scientific Inc. generate?

Operating cash flow of $278 million less capital expenditures of $729 million gives free cash flow of -$451 million for fiscal 2025.

References

Related Pages